Migreen kliinilised uuringud osariigis Virginia
7 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Virginia.
Linnad osariigis Virginia
Ametlik uuringutekst (inglise keeles)
Study of EVO756 in Adults With Migraine
- MedStar Health: Headache Center at McLean, McLean
VärbamineFaas 2
Vanused 18–64 · Kõik sood · Uuendatud 2. okt 2026 · NCT07616128Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- ja veel 2
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- ja veel 2
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
- Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Health Research of Hampton Roads, Inc. (HRHR), Newport News
- AMR Clinical - Norfolk, Norfolk
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Children's Specialty Group - 3 Commercial Place, Norfolk
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 12. juuni 2026 · NCT05164172Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- MedStar Health: Neurology at McLean, McLean
VärbamineFaas 4
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. dets 2025 · NCT07301008Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.